Saniona: partner secures USD 40 million in a series B financing

Research Note

2018-11-15

21:37

Cadent Therapeutics, a partner company to Saniona, announced on Thursday that they had secured a USD 40 million financing to advance its pipeline. Lead candidate is CAD-1883, a compound discovered in a collaboration between Saniona and Cadent Therapeutics.

AH

Anders Hedlund

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.